Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
18.03
+0.42 (2.39%)
At close: Sep 18, 2025, 4:00 PM EDT
17.55
-0.48 (-2.66%)
After-hours: Sep 18, 2025, 7:12 PM EDT
Seres Therapeutics Employees
Seres Therapeutics had 103 employees as of December 31, 2024. The number of employees decreased by 130 or -55.79% compared to the previous year.
Employees
103
Change (1Y)
-130
Growth (1Y)
-55.79%
Revenue / Employee
n/a
Profits / Employee
$834,621
Market Cap
157.84M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103 | -130 | -55.79% |
| Dec 31, 2023 | 233 | -198 | -45.94% |
| Dec 31, 2022 | 431 | 98 | 29.43% |
| Dec 31, 2021 | 333 | 178 | 114.84% |
| Dec 31, 2020 | 155 | 47 | 43.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MCRB News
- 22 days ago - Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 weeks ago - Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA Breakthrough - Seeking Alpha
- 2 months ago - Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025 - GlobeNewsWire
- 2 months ago - Seres Therapeutics Announces Leadership Transition - GlobeNewsWire
- 4 months ago - Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting - GlobeNewsWire
- 4 months ago - Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript - Seeking Alpha